Location
Los Angeles, CA
Signature
Oaktree GCP Fund Delaware Holdings, L.P., By: Oaktree Global Credit Plus Fund GP, L.P., Its: GP, By: Oaktree Global Credit Plus Fund GP Ltd., Its: GP, By: Oaktree Capital Management, L.P., Its: Director, /s/ Henry Orren, Senior Vice President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Oaktree GCP Fund Delaware Holdings, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC 10%+ Owner Warrants 3,117,057 30 Nov 2023 Indirect

Insider Reports Filed by Oaktree GCP Fund Delaware Holdings, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123056253-oaktree-gcp-fund-delaware-holdings-l-p-2023-11-30 IMPEL PHARMACEUTICALS INC 30 Nov 2023 1 $0 4 10%+ Owner 04 Dec 2023, 21:00
/report/000114036123054076-oaktree-gcp-fund-delaware-holdings-l-p-2023-11-10 IMPEL PHARMACEUTICALS INC 10 Nov 2023 0 $0 3 10%+ Owner 20 Nov 2023, 21:12